ArticleCell reports. Medicine2026

Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers.

Meijie Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.